Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares stood at 1.55 million during the last session, with the company’s beta value hitting 2.27. At the close of trading, the stock’s price was $0.33, to imply a decrease of -2.42% or -$0.01 in intraday trading. The TNXP share’s 52-week high remains $4.00, putting it -1112.12% down since that peak but still an impressive 21.21% since price per share fell to its 52-week low of $0.26. The company has a valuation of $26.42M, with an average of 1.65 million shares in intraday trading volume over the past 10 days and average of 1.46 million shares over the past 3 months.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
After registering a -2.42% downside in the last session, Tonix Pharmaceuticals Holding Corp (TNXP) has traded red over the past five days. The stock hit a weekly high of 0.3657, dropping -2.42% in its intraday price action. The 5-day price performance for the stock is -8.71%, and -11.17% over 30 days. With these gigs, the year-to-date price performance is -18.88%. Short interest in Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw shorts transact 0.62 million shares and set a 0.53 days time to cover.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
Looking at statistics comparing Tonix Pharmaceuticals Holding Corp share performance against respective industry, we note that the company has outperformed competitors. Tonix Pharmaceuticals Holding Corp (TNXP) shares are -58.62% down over the last 6 months, with its year-to-date growth rate higher than industry average at 59.05% against 10.40%. Revenue is forecast to grow 53.10% this quarter before jumping 58.50% for the next one.
Revenue forecast for the current quarter as set by 3 analysts is $3.83 million. Meanwhile, for the quarter ending Mar 2024, a total of 1 analyst(s) estimate revenue growth to $7.5 million.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp has its next earnings report out between May 06 and May 10. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Tonix Pharmaceuticals Holding Corp has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Tonix Pharmaceuticals Holding Corp insiders hold 0.01% of total outstanding shares, with institutional holders owning 28.61% of the shares at 28.61% float percentage. In total, 28.61% institutions holds shares in the company, led by Vanguard Group Inc. As of Jun 29, 2023, the company held over 0.4 million shares (or 2.24% of shares), all amounting to roughly $0.63 million.
The next major institution holding the largest number of shares is Renaissance Technologies, LLC with 0.21 million shares, or about 1.19% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $0.33 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Tonix Pharmaceuticals Holding Corp (TNXP) shares. Going by data provided on Jun 29, 2023, Vanguard Total Stock Market Index Fund holds roughly 0.3 million shares. This is just over 1.67% of the total shares, with a market valuation of $0.47 million. Data from the same date shows that the other fund manager holds a little less at 0.1 million, or 0.57% of the shares, all valued at about 0.16 million.
